tiprankstipranks
Xeris Pharmaceuticals (XERS)
NASDAQ:XERS
US Market

Xeris Pharmaceuticals (XERS) Income Statement

Compare
976 Followers

Xeris Pharmaceuticals Income Statement

Last quarter (Q4 2024), Xeris Pharmaceuticals's total revenue was $60.10M, an increase of 35.39% from the same quarter last year. In Q4, Xeris Pharmaceuticals's net income was $-5.11M. See Xeris Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 203.07M$ 163.91M$ 110.25M$ 110.25M$ 49.59M
Gross Profit
$ 166.24M$ 135.27M$ 87.61M$ 87.61M$ 36.27M
Operating Expenses
$ 199.88M$ 179.28M$ 169.55M$ 169.55M$ 151.43M
Depreciation and Amortization
$ 12.63M$ 13.16M$ 12.67M$ 1.88M$ 1.47M
EBITDA
$ -13.99M$ -23.73M$ -69.31M$ -113.67M$ -80.08M
Operating Income
$ -33.65M$ -44.01M$ -81.94M$ -81.94M$ -115.16M
Other Income/Expenses
$ -23.46M$ -19.49M$ -14.14M$ -7.57M$ -7.70M
Pretax Income
$ -57.10M$ -63.50M$ -96.08M$ -96.08M$ -122.72M
Net Income
$ -54.84M$ -62.26M$ -94.66M$ -94.66M$ -122.72M
Per Share Metrics
Basic EPS
$ -0.37$ -0.45$ -0.70$ -1.20$ -2.88
Diluted EPS
$ -0.37$ -0.45$ -0.70$ -1.20$ -2.88
Weighted Average Shares Outstanding
146.77M 137.67M 135.63M 79.03M 42.64M
Weighted Average Shares Outstanding (Diluted)
146.77M 137.67M 135.63M 79.03M 42.64M
Currency in USD

Xeris Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis